Status:

COMPLETED

Safety and Efficacy of MCC-257 in the Treatment of Diabetic Polyneuropathy

Lead Sponsor:

Tanabe Pharma Corporation

Conditions:

Diabetic Polyneuropathy

Eligibility:

All Genders

18-70 years

Phase:

PHASE2

Brief Summary

The primary objectives of the study are to evaluate the efficacy and safety of three doses of MCC-257 in patients with mild to moderate diabetic polyneuropathy

Detailed Description

The study will use a double-blind, randomized, placebo-controlled, fixed-dose, parallel-group design. Patients will be randomized equally to 1 of 4 treatment groups: MCC-257 20 mg, MCC-257 40 mg, MCC-...

Eligibility Criteria

Inclusion

  • The patient is male or female, 18-70 years of age
  • The patient has either type 1 or type 2 diabetes
  • The patient has mild to moderate diabetic neuropathy
  • The patient is free from other clinically significant illness or disease, as determined by medical history, physical examination, laboratory evaluations, and other safety tests

Exclusion

  • Being treated with anticoagulants other than aspirin, such as warfarin, digoxin, Plavix
  • BMI\>40
  • A significant disorder or a condition other than diabetes that can cause symptoms or physical conditions that mimic peripheral neuropathy or interfere with cognition
  • Any proximal neuropathy, clinically evident nerve entrapment, or any focal trauma potentially affecting nerve function
  • Women of childbearing potential who do not refrain from sexual activity or use adequate contraception
  • Pregnant or lactating women
  • An ALT or AST value \>2X upper limit of normal (ULN)
  • Clinically significant cardiovascular disease within the last six (6) months

Key Trial Info

Start Date :

March 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2007

Estimated Enrollment :

420 Patients enrolled

Trial Details

Trial ID

NCT00307749

Start Date

March 1 2006

End Date

August 1 2007

Last Update

December 28 2007

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Safety and Efficacy of MCC-257 in the Treatment of Diabetic Polyneuropathy | DecenTrialz